GlassScriptPhysician profile
Meghan E Viader
NPI 1649582289
$408.35
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $243 · 2024: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $408.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $408.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seqirus USA INC | $67.98 | 2023-2024 | Flucelvax Quadrivalent, Flucelvax |
| Pfizer INC. | $52.08 | 2023 | |
| Ironshore Pharmaceuticals INC. | $45.49 | 2023 | Jornay Pm |
| Baxter Healthcare | $41.99 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Sanofi Pasteur INC. | $35.17 | 2023 | |
| Tempus Ai, INC | $29.75 | 2024 | |
| Sobi, INC | $25.62 | 2023 | |
| Glaxosmithkline, LLC. | $24.85 | 2023 | Bexsero, Rotarix |
| Astrazeneca Pharmaceuticals LP | $22.36 | 2024 | Flumist Quadrivalent |
| Kaleo, INC. | $19.68 | 2024 | Auvi-Q |
| Sanofi-Aventis U.S. LLC | $16.69 | 2024 | |
| Merck Sharp & Dohme LLC | $13.93 | 2024 | Gardasil, Vaxelis, Gardasil 9 |
| Nestle Healthcare Nutrition INC. | $12.76 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meghan Viader listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.